Lista de

protein p53
38
"Involvement of leptin in the molecular physiology of the placenta" (2018) Schanton, M.;Maymó, J.L.;Pérez-Pérez, A. (...)Varone, C.L. Reproduction. 155(1):R1-R12
"Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation" (2018) Maymó, J.L.;Riedel, R.;Pérez-Pérez, A. (...)Varone, C.L. PLoS ONE. 13(1)
"Inhibition of Cell Division and DNA Replication Impair Mouse-Naïve Pluripotency Exit" (2017) Waisman, A.;Vazquez Echegaray, C.;Solari, C. (...)Guberman, A. Journal of Molecular Biology. 429(18):2802-2815
"Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase" (2017) Giono, L.E.;Resnick-Silverman, L.;Carvajal, L.A. (...)Manfredi, J.J. Oncogene. 36(49):6762-6773
"Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase" (2017) Giono, L.E.;Resnick-Silverman, L.;Carvajal, L.A. (...)Manfredi, J.J. Oncogene. 36(49):6762-6773
"The RNA Response to DNA Damage" (2016) Giono, L.E.;Nieto Moreno, N.;Cambindo Botto, A.E. (...)Kornblihtt, A.R. Journal of Molecular Biology. 428(12):2636-2651
"Mechanisms involved in p53 downregulation by leptin in trophoblastic cells" (2015) Toro, A.R.;Pérez-Pérez, A.;Corrales Gutiérrez, I. (...)Varone, C.L. Placenta. 36(11):1266-1275
"Mechanisms involved in p53 downregulation by leptin in trophoblastic cells" (2015) Toro, A.R.;Pérez-Pérez, A.;Corrales Gutiérrez, I. (...)Varone, C.L. Placenta. 36(11):1266-1275
"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960
"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960
"Human MageB2 protein expression enhances E2F transcriptional activity, cell proliferation, and resistance to ribotoxic stress" (2015) Peche, L.Y.;Ladelfa, M.F.;Toledo, M.F. (...)Monte, M. Journal of Biological Chemistry. 290(49):29652-29662
"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255
"Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation" (2014) Toro, A.R.;Maymó, J.L.;Ibarbalz, F.M. (...)Varone, C.L. PLoS ONE. 9(6)
"Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation" (2014) Toro, A.R.;Maymó, J.L.;Ibarbalz, F.M. (...)Varone, C.L. PLoS ONE. 9(6)
"Folding of a cyclin box: Linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor ab pocket domain" (2013) Chemes, L.B.; Noval, M.G.; Sánchez, I.E.; De Prat-Gay, G. Journal of Biological Chemistry. 288(26):18923-18938
"BRCA1 and p53 regulate critical prostate cancer pathways" (2013) De Luca, P.;Moiola, C.P.;Zalazar, F. (...)De Siervi, A. Prostate Cancer and Prostatic Diseases. 16(3):233-238
"Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways" (2013) Ceruti, J.M.;Ogara, M.F.;Menéndez, C. (...)Cánepa, E.T. Molecular and Cellular Biochemistry. 378(1-2):117-126
"A monoclonal antibody against p53 cross-reacts with processing bodies" (2012) Thomas, M.G.;Luchelli, L.;Pascual, M. (...)Boccaccio, G.L. PLoS ONE. 7(5)
"A monoclonal antibody against p53 cross-reacts with processing bodies" (2012) Thomas, M.G.;Luchelli, L.;Pascual, M. (...)Boccaccio, G.L. PLoS ONE. 7(5)
"Tumor-specific MAGE proteins as regulators of p53 function" (2012) Ladelfa, M.F.;Peche, L.Y.;Toledo, M.F. (...)Monte, M. Cancer Letters. 325(1):11-17
"DNA damage-induced heterogeneous nuclear ribonucleoprotein K SUMOylation regulates p53 transcriptional activation" (2012) Pelisch, F.;Pozzi, B.;Risso, G. (...)Srebrow, A. Journal of Biological Chemistry. 287(36):30789-30799
"MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs" (2012) Peche, L.Y.;Scolz, M.;Ladelfa, M.F. (...)Schneider, C. Cell Death and Differentiation. 19(6):926-936
"Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer" (2011) Chauchereau, A.;Al Nakouzi, N.;Gaudin, C. (...)Fizazi, K. Experimental Cell Research. 317(3):262-275
"Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice" (2011) Frick, L.R.;Rapanelli, M.;Arcos, M.L.B. (...)Genaro, A.M. European Journal of Pharmacology. 659(2-3):265-272
"Key questions in metastasis: New insights in molecular pathways and therapeutic implications" (2011) Gueron, G.; de Siervi, A.; Vazquez, E. Current Pharmaceutical Biotechnology. 12(11):1867-1880
"Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production" (2011) Ladelfa, M.F.; Toledo, M.F.; Laiseca, J.E.; Monte, M. Antioxidants and Redox Signaling. 15(6):1749-1761
"The serine/arginine-rich protein SF2/ASF regulates protein sumoylation" (2010) Pelisch, F.;Gerez, J.;Druker, J. (...)Srebrow, A. Proceedings of the National Academy of Sciences of the United States of America. 107(37):16119-16124
"DNA Damage Regulates Alternative Splicing through Inhibition of RNA Polymerase II Elongation" (2009) Muñoz, M.J.;Santangelo, M.S.P.;Paronetto, M.P. (...)Kornblihtt, A.R. Cell. 137(4):708-720
"Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus" (2004) Galigniana, M.D.;Harrell, J.M.;O'Hagen, H.M. (...)Pratt, W.B. Journal of Biological Chemistry. 279(21):22483-22489
"Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex" (2004) Galigniana, M.D.; Morishima, Y.; Gallay, P.A.; Pratt, W.B. Journal of Biological Chemistry. 279(53):55754-55759
"Cell cycle arrest and modulation of HO-1 expression induced by acetyl salicylic acid in hepatocarcinogenesis" (2004) Sacca, P.; Caballero, F.; Batlle, A.; Vazquez, E. International Journal of Biochemistry and Cell Biology. 36(10):1945-1953
"New treatment strategies based on apoptosis and viruses " (2003) Mersich, S.; Gadaleta, P. Acta Bioquimica Clinica Latinoamericana. 37(1):13-19
"p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells" (2002) Martinez, L.A.;Yang, J.;Vazquez, E.S. (...)Navone, N.M. Carcinogenesis. 23(8):1289-1296
"Delta-aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines." (2002) De Siervi, A.;Vazquez, E.S.;Rezaval, C. (...)del Batlle, A.M. BMC cancer [electronic resource]. 2(1):6
"Apoptosis in Schwann cell cultures is closely interrelated with the activity of the ubiquitin-proteasome proteolytic pathway" (2002) Pasquini, L.A.; Besio Moreno, M.; Lopez Salon, M.; Soto, E.F. Neurochemical Research. 27(11):1401-1419